
Preclinical Imaging Market Size, Share, and Analysis, By Product (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, and Nuclear Imaging Reagents), By Application (Oncology, Neurology, and Others), By End-User (Pharmaceutical, Imaging
Description
Preclinical Imaging Market Size, Share, and Analysis, By Product (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, and Nuclear Imaging Reagents), By Application (Oncology, Neurology, and Others), By End-User (Pharmaceutical, Imaging Centers, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
Preclinical Imaging Market Size, Share, and Analysis, By Product (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, and Nuclear Imaging Reagents), By Application (Oncology, Neurology, and Others), By End-User (Pharmaceutical, Imaging Centers, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Preclinical Imaging Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2.8 billion and is projected to reach USD 4.7 billion by the completion of 2034.
Preclinical imaging is a branch of medical imaging that studies biological procedures and disorders in tiny animal models, like mice or rats, before performing human trials. Various imaging techniques, such as MRI, PET, CT, and optical imaging, are used to visualize anatomical features, molecular interactions, and physiological activities at the cellular and molecular levels. Additionally, scientists can use non-invasive imaging techniques to track the progression of disease, assess the efficacy of treatment, and study the underlying causes of illness. Preclinical imaging is important in drug development as it allows researchers to assess new treatments, along with understanding their pharmacokinetics and pharmacodynamics, and make informed decisions before moving on to human trials. As a result, preclinical imaging provides an important link between fundamental research and practical medical applications, as it helps in the transitioning of new treatments.
MARKET HIGHLIGHTS
Preclinical Imaging Market is projected to reach USD 4.7 billion over the forecast period, due to the growth in research & development efforts in the pharmaceutical and biotechnology sectors. The enhanced technology of imaging modalities such as MRI, PET, SPECT, and CT has increased their ability to study molecular and cellular processes in small animal models. In addition, the rising need for personalized medicine and accurate treatments has led to high investment in preclinical imaging for drug discovery and development. Moreover, the increasing occurrence of chronic illnesses such as cancer and neurological disorders highlights the importance of gaining a deeper understanding of disease mechanisms, which further promotes the adoption of preclinical imaging. Therefore, the preclinical imaging market is expected to grow due to the growing use of advanced imaging technologies and the higher investment in biomedical research.
Preclinical Imaging Market Segments:
- By Product
- Optical Imaging
- PET
- SPECT
- Optical Imaging Reagents
- Contrast Agents
- Nuclear Imaging Reagents
- By Application
- Oncology
- Neurology
- Others
- By End-User
- Pharmaceutical
- Imaging Centers
- Others
Growth Drivers
Advancements in Preclinical Imaging Technology to Drive Growth in the Preclinical Imaging Market
Increasing Prevalence of Chronic Diseases Act as a Catalyst for Market Growth
Restraint
Cost of Equipment and Maintenance in the Preclinical Imaging Market Will Impact the Growth
Key Players
- Bruker Corporation
- PerkinElmer, Inc.
- Siemens Healthineers AG
- GE Healthcare
- MR Solutions
- Aspect Imaging Ltd.
- Mediso Medical Imaging Systems
- MILabs B.V.
- TriFoil Imaging
- Agilent Technologies, Inc.
- Fujifilm Holdings Corporation
- Thermo Fisher Scientific Inc.
- Miltenyi Biotec
- LI-COR Biosciences
- Perceptive Instruments Ltd.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
563 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2.Business Trends
- 1.3. Preclinical Imaging Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1.Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4.Primary Research
- 2.5.Secondary Research
- 2.5.1.Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1.Market Definition
- 3.2.Preclinical Imaging Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4.Key Developments
- 3.5.Allied Industry Data
- 4.Preclinical Imaging Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2.COVID-19 overview of world economy
- 4.3.Industry Ecosystem Channel Analysis
- 4.4.Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7. Market Dynamics
- 7.1.Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4.Market Restraints
- 7.5. Market Trends
- 8.Risk Analysis
- 9. Market Analysis
- 9.1.Porter's Five Forces
- 9.2. PEST Analysis
- 9.2.1.Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10.Preclinical Imaging Market
- 10.1.Overview
- 10.2. Historical Analysis (2019-2022)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11. Preclinical Imaging Market Size & Forecast 2024A-2034F
- 11.1. Overview
- 11.2.Key Findings
- 11.3.Market Segmentation
- 11.3.1. By Product
- 11.3.1.1. Optical Imaging
- 11.3.1.1.1.By Value (USD Million) 2024-2034F
- 11.3.1.1.2. Market Share (%) 2024-2034F
- 11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
- 11.3.1.2.PET
- 11.3.1.2.1. By Value (USD Million) 2024-2034F
- 11.3.1.2.2.Market Share (%) 2024-2034F
- 11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.1.3.SPECT
- 11.3.1.3.1. By Value (USD Million) 2024-2034F
- 11.3.1.3.2.Market Share (%) 2024-2034F
- 11.3.1.3.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.1.4.Optical Imaging Reagents
- 11.3.1.4.1. By Value (USD Million) 2024-2034F
- 11.3.1.4.2.Market Share (%) 2024-2034F
- 11.3.1.4.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.1.5.Contrast Agents
- 11.3.1.5.1. By Value (USD Million) 2024-2034F
- 11.3.1.5.2.Market Share (%) 2024-2034F
- 11.3.1.5.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.1.6.Nuclear Imaging Reagents
- 11.3.1.6.1. By Value (USD Million) 2024-2034F
- 11.3.1.6.2.Market Share (%) 2024-2034F
- 11.3.1.6.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.2. By Application
- 11.3.2.1.Oncology
- 11.3.2.1.1. By Value (USD Million) 2024-2034F
- 11.3.2.1.2.Market Share (%) 2024-2034F
- 11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.2.2. Neurology
- 11.3.2.2.1.By Value (USD Million) 2024-2034F
- 11.3.2.2.2. Market Share (%) 2024-2034F
- 11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
- 11.3.2.3. Others
- 11.3.2.3.1.By Value (USD Million) 2024-2034F
- 11.3.2.3.2. Market Share (%) 2024-2034F
- 11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
- 11.3.3.By End-User
- 11.3.3.1.Pharmaceutical
- 11.3.3.1.1. By Value (USD Million) 2024-2034F
- 11.3.3.1.2.Market Share (%) 2024-2034F
- 11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F
- 11.3.3.2. Imaging Centers
- 11.3.3.2.1.By Value (USD Million) 2024-2034F
- 11.3.3.2.2. Market Share (%) 2024-2034F
- 11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
- 11.3.3.3. Others
- 11.3.3.3.1.By Value (USD Million) 2024-2034F
- 11.3.3.3.2. Market Share (%) 2024-2034F
- 11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
- 12.North America Preclinical Imaging Market Size & Forecast 2024A-2034F
- 12.1.Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1.By Product
- 12.3.2. By Application
- 12.3.3. By End-User
- 12.4. Country
- 12.4.1. United States
- 12.4.2.Canada
- 13.Europe Preclinical Imaging Market Size & Forecast 2024A-2034F
- 13.1.Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1.By Product
- 13.3.2. By Application
- 13.3.3. By End-User
- 13.4.Country
- 13.4.1.Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14.Asia-Pacific Preclinical Imaging Market Size & Forecast 2024A-2034F
- 14.1. Overview
- 14.2. Key Findings
- 14.3.Market Segmentation
- 14.3.1.By Product
- 14.3.2. By Application
- 14.3.3. By End-User
- 14.4.Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4.Japan
- 14.4.5.Rest of APAC
- 15.Middle East and Africa Preclinical Imaging Market Size & Forecast 2024A-2034F
- 15.1.Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1.By Product
- 15.3.2. By Application
- 15.3.3. By End-User
- 15.4.Country
- 15.4.1. Israel
- 15.4.2.GCC
- 15.4.3.North Africa
- 15.4.4.South Africa
- 15.4.5.Rest of Middle East and Africa
- 16. Latin America Preclinical Imaging Market Size & Forecast 2024A-2034F
- 16.1.Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1.By Product
- 16.3.2. By Application
- 16.3.3. By End-User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2.Brazil
- 16.4.3.Rest of Latin America
- 17. Competitive Landscape
- 17.1.Company market share, 2023
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1. Bruker Corporation
- 18.1.1.Company Overview
- 18.1.2.Financial Overview
- 18.1.3.Key Product; Analysis
- 18.1.4.Company Assessment
- 18.1.4.1.Product Portfolio
- 18.1.4.2.Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2.PerkinElmer, Inc.
- 18.3.Siemens Healthineers AG
- 18.4. GE Healthcare
- 18.5. MR Solutions
- 18.6.Aspect Imaging Ltd.
- 18.7.Mediso Medical Imaging Systems
- 18.8. MILabs B.V.
- 18.9.TriFoil Imaging
- 18.10.Agilent Technologies, Inc.
- 18.11. Fujifilm Holdings Corporation
- 18.12.Thermo Fisher Scientific Inc.
- 18.13.Miltenyi Biotec
- 18.14.LI-COR Biosciences
- 18.15.Perceptive Instruments Ltd.
- 18.16.Other Prominent Players
- 19. Appendix
- 20.Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.